CCL11 and Bartsocas-Papas syndrome 1: Among the patients with IC/BPS, BOO, DO, and HSB, using a higher urinary level of eotaxin (≥2.290 pg/mL) or TNF-α (≥1.165 pg/mL), most of the patients with IC/BPS can be identified from the other LUTD subgroups.